The Endometriotic Tumor Microenvironment in Ovarian Cancer

Jillian R Hufgard Wendel; Jillian R. H. Wendel; Xiyin Wang; Shannon M Hawkins

doi:10.3390/cancers10080261

The Endometriotic Tumor Microenvironment in Ovarian Cancer

Jillian R Hufgard Wendel, Jillian R. H. Wendel, Xiyin Wang, Shannon M Hawkins

Cancers · 2018 · vol. 10(8) , pp. 261 · doi:10.3390/cancers10080261 · PMID:30087267 · W2885482298

review OA: gold CC0 ⤵ 30 in-corpus citations

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This review examines the unique molecular features of endometriosis-associated ovarian cancers and their tumor microenvironment, highlighting challenges and potential therapeutic avenues.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Women with endometriosis are at increased risk of developing ovarian cancer, specifically ovarian endometrioid, low-grade serous, and clear-cell adenocarcinoma. An important clinical caveat to the association of endometriosis with ovarian cancer is the improved prognosis for women with endometriosis at time of ovarian cancer staging. Whether endometriosis-associated ovarian cancers develop from the molecular transformation of endometriosis or develop because of the endometriotic tumor microenvironment remain unknown. Additionally, how the presence of endometriosis improves prognosis is also undefined, but likely relies on the endometriotic microenvironment. The unique tumor microenvironment of endometriosis is composed of epithelial, stromal, and immune cells, which adapt to survive in hypoxic conditions with high levels of iron, estrogen, and inflammatory cytokines and chemokines. Understanding the unique molecular features of the endometriotic tumor microenvironment may lead to impactful precision therapies and/or modalities for prevention. A challenge to this important study is the rarity of well-characterized clinical samples and the limited model systems. In this review, we will describe the unique molecular features of endometriosis-associated ovarian cancers, the endometriotic tumor microenvironment, and available model systems for endometriosis-associated ovarian cancers. Continued research on these unique ovarian cancers may lead to improved prevention and treatment options.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (30)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-04T00:00:01.174412+00:00
pubmed: last seen: 2026-05-13T22:19:37.156494+00:00

License: CC0 · commercial use OK

[1] Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis via openalex

[2] Aberrant Expression of the Mammalian Target of Rapamycin, Hypoxia-inducible Factor-1α, and Glucose Transporter 1 in the Development of Ovarian Clear-cell Adenocarcinoma via openalex

[3] A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells via openalex

[4] Activation of mutated K‐ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis via openalex

[5] Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients via openalex

[6] Analysis of the oncogene BRAF mutation and the correlation of the expression of wild-type BRAF and CREB1 in endometriosis via openalex

[7] A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis via openalex

[8] A Novel Mouse Model of Endometriosis Mimics Human Phenotype and Reveals Insights into the Inflammatory Contribution of Shed Endometrium via openalex

[9] A potential link of oxidative stress and cell cycle regulation for development of endometriosis via openalex

[10] Association between endometriosis and cancer: A comprehensive review and a critical analysis of clinical and epidemiological evidence via openalex

[11] Autophagy contributes to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis† via openalex

[12] BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer via openalex

[13] <b>Ovarian atypical endometriosis: its close association with malignant epithelial tumours</b> via openalex

[14] Cancer-Associated Mutations in Endometriosis without Cancer via openalex

[15] Cancer risk after a hospital discharge diagnosis of endometriosis via openalex

[16] CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis via openalex

[17] Co‐culture with macrophages enhances the clonogenic and invasion activity of endometriotic stromal cells via openalex

[18] Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis via openalex

[19] Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress via openalex

[20] Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability via openalex

[21] Discovery of Phosphatidic Acid, Phosphatidylcholine, and Phosphatidylserine as Biomarkers for Early Diagnosis of Endometriosis via openalex

[22] Distinct developmental trajectories of endometriotic epithelium and stroma: implications for the origins of endometriosis via openalex

[23] Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis via openalex

[24] DNA methylation alterations—potential cause of endometriosis pathogenesis or a reflection of tissue heterogeneity?† via openalex

[25] Does the Presence of Endometriosis Affect Prognosis of Ovarian Cancer? via openalex

[26] Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why via openalex

[27] Endometrioid Adenocarcinoma of the Ovary and Its Relationship to Endometriosis via openalex

[28] Endometriosis via openalex

[29] Endometriosis, a disease of the macrophage via openalex

[30] Endometriosis as a prognostic factor for cancer survival via openalex

[31] Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis via openalex

[32] Endometriosis-associated Ovarian Cancers via openalex

[33] Endometriosis: benign, malignant, or something in between? via openalex

[34] Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology via openalex

[35] Endometriosis: Its association with retrograde menstruation, dysmenorrhoea and tubal pathology via openalex

[36] Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis via openalex

[37] Epidemiology of ovarian cancer: a review via openalex

[38] Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis via openalex

[39] Evidence from a Mouse Model That Epithelial Cell Migration and Mesenchymal-Epithelial Transition Contribute to Rapid Restoration of Uterine Tissue Integrity during Menstruation via openalex

[40] Expression of miR-126 and Crk in endometriosis: miR-126 may affect the progression of endometriosis by regulating Crk expression via openalex

[41] Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis via openalex

[42] Functional MicroRNA Involved in Endometriosis via openalex

[43] Human Endometrial Fibroblasts Derived from Mesenchymal Progenitors Inherit Progesterone Resistance and Acquire an Inflammatory Phenotype in the Endometrial Niche in Endometriosis1 via openalex

[44] Hypoxia-Induced MicroRNA-20a Expression Increases ERK Phosphorylation and Angiogenic Gene Expression in Endometriotic Stromal Cells via openalex

[45] Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis via openalex

[46] Hypoxia-inducible factor-1α promotes endometrial stromal cells migration and invasion by upregulating autophagy in endometriosis via openalex

[47] Hypoxia‐inhibited DUSP2 expression promotes IL‐6/STAT3 signaling in endometriosis via openalex

[48] Hypoxia Promotes Ectopic Adhesion Ability of Endometrial Stromal Cells via TGF-β1/Smad Signaling in Endometriosis via openalex

[49] <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex

[50] ID2 mediates the transforming growth factor-β1-induced Warburg-like effect seen in the peritoneum of women with endometriosis via openalex

[51] Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex

[52] Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis via openalex

[53] Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis via openalex

[54] Incidence of endometriosis by study population and diagnostic method: the ENDO study via openalex

[55] Increased Mitogen-Activated Protein Kinase Kinase/Extracellularly Regulated Kinase Activity in Human Endometrial Stromal Fibroblasts of Women with Endometriosis Reduces 3′,5′-Cyclic Adenosine 5′-Monophosphate Inhibition of Cyclin D1 via openalex

[56] Inhibition of dual specificity phosphatase-2 by hypoxia promotes interleukin-8-mediated angiogenesis in endometriosis via openalex

[57] KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance via openalex

[58] KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis via openalex

[59] Lipidomic profiling of endometrial fluid in women with ovarian endometriosis† via openalex

[60] Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium via openalex

[61] Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? via openalex

[62] Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma. via openalex

[63] Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma via openalex

[64] Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. via openalex

[65] Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of Disease via openalex

[66] MicroRNAs and Endometriosis: Distinguishing Drivers from Passengers in Disease Pathogenesis via openalex

[67] miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples via openalex

[68] Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma via openalex

[69] Molecular and Cellular Pathogenesis of Endometriosis via openalex

[70] Molecular and preclinical basis to inhibit PGE <sub>2</sub> receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis via openalex

[71] Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis via openalex

[72] Origin of clear cell carcinoma: nature or nurture? via openalex

[73] Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype via openalex

[74] Ovarian endometriosis-associated stromal cells reveal persistently high affinity for iron via openalex

[75] Pathological functions of hypoxia in endometriosis via openalex

[76] Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? via openalex

[77] Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis via openalex

[78] Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer via openalex

[79] Population Distribution of Lifetime Risk of Ovarian Cancer in the United States via openalex

[80] Practice Bulletin No. 114: Management of Endometriosis via openalex

[81] Prevalence of endometriosis in epithelial ovarian cancer. Analysis of the associated clinical features and study on molecular mechanisms involved in the possible causality. via openalex

[82] Psychosocial impact of endometriosis: From co-morbidity to intervention via openalex

[83] Regulation of Steroidogenic Acute Regulatory Protein Expression and Progesterone Production in Endometriotic Stromal Cells via openalex

[84] Relevant human tissue resources and laboratory models for use in endometriosis research via openalex

[85] Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan via openalex

[86] Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery via openalex

[87] Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer via openalex

[88] Steroidogenic Enzyme and Key Decidualization Marker Dysregulation in Endometrial Stromal Cells from Women with Versus Without Endometriosis1 via openalex

[89] Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17β-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism via openalex

[90] Surgical Treatment of Endometriosis via openalex

[91] Ten-Eleven Translocation Genes are Downregulated in Endometriosis via openalex

[92] The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention via openalex

[93] The Peritoneum Is Both a Source and Target of TGF-β in Women with Endometriosis via openalex

[94] The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis via openalex

[95] The Progesterone Receptor Coactivator Hic-5 Is Involved in the Pathophysiology of Endometriosis via openalex

[96] The Protein Kinase A Pathway-Regulated Transcriptome of Endometrial Stromal Fibroblasts Reveals Compromised Differentiation and Persistent Proliferative Potential in Endometriosis via openalex

[97] Transforming Growth Factor-β Induced Warburg-Like Metabolic Reprogramming May Underpin the Development of Peritoneal Endometriosis via openalex

[98] Tumour necrosis factor α concentrations in the peritoneal fluid of infertile women with minimal or mild endometriosis are lower in patients with red lesions only than in patients without red lesions via openalex

[99] Unique Transcriptome, Pathways, and Networks in the Human Endometrial Fibroblast Response to Progesterone in Endometriosis via openalex

[100] W2043781308 via openalex